reviewTop 1% cited
The mechanism of action of MF59 – An innately attractive adjuvant formulation
Vaccine · 2012 · Vol. 30(29) · pp. 4341–4348
Derek T. O’Hagan✉(Novartis (Netherlands))Gary Ott(Dynavax Technologies (United States))Ennio De Gregorio(Novartis (Italy))Anja Seubert(Novartis (Italy))
Influenza Virus Research StudiesImmune Response and InflammationImmunotherapy and Immune ResponsesAdjuvantImmune systemInfluenza vaccineMechanism (biology)Mechanism of actionMedicineVaccine adjuvantImmunologyClinical trialBiology
MeSH terms
Adjuvants, ImmunologicAnimalsHumansInfluenza VaccinesPolysorbatesSqualene
Citations
462
FWCI
18.28
field-weighted impact
References
35
Percentile
100%
vs. same field & year
Citations per year
References
Related articles
Vaccine adjuvants revisited
Vaccine · 2007 · 492 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.